Search for: "Henry v. Pfizer, Inc" Results 1 - 19 of 19
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Sep 2015, 5:47 pm by Lawrence B. Ebert
The caption of the famous Selden car case which found Henry Ford did not infringe the Selden patent is -- Columbia Motor Car Co. et al. v. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
8 Oct 2015, 5:00 am
Charles Pfizer & Co., 532 P.2d 1377, 1382 (Okla. 1974); Dole Food Co. v. [read post]
13 Dec 2015, 4:01 pm
.* I financed it so it's my copyright--well, not reallyKat friend Aaron Wood has provided an edifying summary of a recent case from the UK Intellectual Property Enterprise Court, Henry Hadaway Organisation v Pickwick Group Limited and Ors [2015] EWHC 3407 (IPEC), concerning the vexing question that copyright practitioners know all too well: Who is the owner of the copyright in a recording where one party finances and the other is the creative/organiser? [read post]
2 Oct 2008, 12:36 pm
Henry's Drug Store, 457 So.2d 561, 562 (Fla. [read post]
13 Sep 2007, 10:48 am
Jude Medical, Inc., 425 F.3d 1116, 1119-21 (8th Cir. 2005), and Castano v. [read post]
22 Feb 2008, 1:30 pm
  The decision in Reidel v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]